[Negative inotropic effects and constipation caused by verapamil?].
Joost
H G
HG
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der Rheinisch-Westfälischen Technischen Hochschule Aachen.
Müller
A
A
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D009543:Nifedipine / Q000494:pharmacology; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D014700:Verapamil; D009543:Nifedipine